PRINCETON, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced…
Read More

PRINCETON, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced…
Read More